Vasoactive-inotropic score

血管活性 - 正性肌力评分
  • 文章类型: Journal Article
    OBJECTIVE: To determine the predictive role of combined assessment of vasoactive-inotropic score and lactate for the prognosis of patients with postcardiotomy cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.
    METHODS: The data of adult patients with postcardiotomy cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation between January 2015 and December 2018 at a tertiary hospital was retrospectively analyzed. The incidence of in-hospital mortality and other clinical outcomes were analyzed. The associations of vasoactive-inotropic score and lactate and in-hospital mortality were assessed using logistic regression analysis.
    RESULTS: 222 patients were included and divided into four groups according to the cut-off points of vasoactive-inotropic score (24.3) and lactate level (6.85 mmol/L). The in-hospital mortality rates were 37.7%, 50.7%, 54.8% and 76.5% for the four groups (P < 0.001), while the rates of successful weaning off extracorporeal membrane oxygenation were 73.9%, 69%, 61.3% and 39.2% respectively (P = 0.001). The group 1 and group 2 exhibited significant differences compared to group 4 in both in-hospital mortality and weaning rates (P < 0.05). There was a statistically significant difference in the incidence of multiple organ dysfunction between group 1 and group 4 (P < 0.05). Groups 1, 2 and 3 demonstrated significantly improved cumulative 30-day survival compared with group 4 (log-rank test, P < 0.05). Logistic regression analysis revealed that age, vasoactive-inotropic score > 24.3 and lactate > 6.85 mmol/L were independently predictive of in-hospital mortality.
    CONCLUSIONS: Among patients with postcardiotomy cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation, the initiation before reaching vasoactive-inotropic score > 24.3 and lactate > 6.85 mmol/L was associated with improved in-hospital outcomes, suggesting that combined assessment of VIS and lactate may be instructive for determining the initiation of venoarterial extracorporeal membrane oxygenation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    评估机械循环支持(MCS)包括主动脉内球囊反搏(IABP)或静脉动脉体外膜氧合(ECMO),可以帮助改善院外心脏骤停(OHCA)患者的神经系统预后。
    这是一项在中国医科大学附属医院进行的回顾性观察性队列研究,台中,台湾。OHCA成年患者于2015年1月至2023年6月期间入院。血管活性变力剂的定量评分和MCS的定性干预,包括IABP和OHCA后的ECMO。多因素回归评估了通过血管活性肌力评分(VIS)分层的患者中每种MCS方法的疗效。
    共纳入并分析了334例患者,122(36.5%)的神经系统预后良好,215(64.4%)存活≥90天。这些患者通过VIS:0-25、26-100、101-250和>250进行分层。在VIS>100的患者中,与非MCS干预相比,有或没有IABP的ECMO可确保OHCA后良好的神经系统预后和生存率(p<0.001)。对于VIS≤100的患者,单独使用IABP是有益的,与非MCS干预措施没有显着差异(p>0.05)。
    ECMO伴或不伴IABP治疗可改善预期VIS-24h>100患者的OHCA后神经系统结局和生存率(例如,CPR期间肾上腺素剂量达到3mg)。
    UNASSIGNED: To assess whether mechanical circulatory support (MCS), including intra-aortic balloon pump (IABP) or veno-arterial extracorporeal membrane oxygenation (ECMO), can help improve neurological outcomes in patients with out-of-hospital cardiac arrest (OHCA).
    UNASSIGNED: This is a retrospective observational cohort study performed in China Medical University Hospital, Taichung, Taiwan. Adult patients with OHCA admitted between January 2015 and June 2023. Quantitative score of vasoactive-inotropic agents and qualitative interventions of MCS, including IABP and ECMO after OHCA. Multivariate regression evaluated the efficacy of each MCS approach in patients stratified by the vasoactive-inotropic score (VIS).
    UNASSIGNED: A total of 334 patients were included and analyzed, 122 (36.5%) had favorable neurological outcomes and 215 (64.4%) survived ≥90 days. These patients were stratified by VIS: 0-25, 26-100, 101-250, and >250. In patients with a VIS > 100, ECMO with or without IABP ensured favorable neurological outcomes and survival after OHCA compared to non-MCS interventions (p < 0.001). For patients with a VIS ≤ 100, IABP alone was beneficial, with no significant outcome difference from non-MCS interventions (p > 0.05).
    UNASSIGNED: ECMO with or without IABP therapy may improve post-OHCA neurological outcomes and survival in patients with an expected VIS-24 h > 100 (e.g., epinephrine dose reaches 3 mg during CPR).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究使用去甲肾上腺素当量(NEE)评分和血管活性-正性肌力评分(VIS)调查了脓毒症患者血管活性药物暴露与死亡风险之间的关系。
    这项回顾性队列研究包括需要血管活性药物的成人脓毒症患者。数据是从重症监护医学信息集市IV数据库中提取的。主要结果是28天死亡率。多因素Cox回归用于阐明血管活性药物暴露与28天死亡率之间的关系。由VIS和NEE评分量化。产生28天死亡率的95%置信区间(CI)的危险比,和森林地块被构建以呈现单变量和多变量分析的结果。使用Kaplan-Meier方法分析28天死亡率的累积发生率。建立列线图来预测脓毒症患者的预后。
    本研究包括9,032名诊断为脓毒症的患者,他们接受了血管活性疗法,其中4,229例患者在脓毒症发病后第二小时进行了进一步分析。在幸存者(n=3,265,77.21%)和非幸存者(n=964,22.79%)之间观察到人口统计学数据的明显差异。多变量分析表明,几个因素,包括VIS>15.04(p=0.001),NEE>0.10(p<0.001),心率(p=0.045),平均动脉压(p=0.009),呼吸频率(p<0.001),氧饱和度(p<0.001),血尿素氮(BUN)(p=0.001),和急性生理学和慢性健康评估II(p<0.001),与脓毒症患者28日死亡率显著相关.NEE得分,呼吸频率,氧饱和度,和BUN纳入列线图模型,一致性指数为0.779,曲线下面积为0.802(95%CI0.787-0.818).
    我们发现VIS和NEE评分在预测重症监护病房败血症患者的死亡风险方面具有良好的价值。脓毒症患者发病后第2小时的VIS和NEE评分与28天死亡率独立相关。
    UNASSIGNED: This study investigated the association between vasoactive medication exposure and mortality risk in patients with sepsis using the norepinephrine equivalent (NEE) score and vasoactive-inotropic score (VIS).
    UNASSIGNED: This retrospective cohort study included adult patients with sepsis requiring vasoactive agents. The data were extracted from the Medical Information Mart for Intensive Care IV database. The primary outcome was 28-day mortality. Multivariate Cox regression was used to elucidate the relationship between vasoactive medication exposure and 28-day mortality, as quantified by the VIS and NEE score. Hazard ratios with 95% confidence intervals (CI) for 28-day mortality were generated, and forest plots were constructed to present the results of univariate and multivariate analyses. The Kaplan-Meier method was used to analyze the cumulative incidence of 28-day mortality. A nomogram was constructed to predict the prognosis of patients with sepsis.
    UNASSIGNED: The present study encompassed 9,032 patients diagnosed with sepsis who received vasoactive therapy, of which 4,229 patients were further analyzed at the second hour after the onset of sepsis. Distinct variations in demographic data were observed between survivors (n = 3,265, 77.21%) and non-survivors (n = 964, 22.79%). Multivariate analysis indicated that several factors, including VIS >15.04 (p = 0.001), NEE >0.10 (p < 0.001), heart rate (p = 0.045), mean arterial pressure (p = 0.009), respiratory rate (p < 0.001), oxygen saturation (p < 0.001), blood urea nitrogen (BUN) (p = 0.001), and the Acute Physiology and Chronic Health Evaluation II (p < 0.001), were significantly associated with 28-day mortality in the patients with sepsis. The NEE score, respiratory rate, oxygen saturation, and BUN were incorporated into the nomogram model with a concordance index of 0.779 and an area under the curve of 0.802 (95% CI 0.787-0.818).
    UNASSIGNED: We found that the VIS and NEE score had favorable values for predicting mortality risk in patients with sepsis in the intensive care units. The VIS and NEE score in the second hour after sepsis onset were independently associated with 28-day mortality in patients with sepsis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在心脏移植后的早期,缺乏指导术后管理的预测工具.没有很好地说明血管活性-正性肌力评分(VIS)是否可以帮助这种预测。
    总共,其中包括2015年1月至2018年12月在我们中心接受心脏移植的325例成年患者。计算术后24h内的最大VIS(VISmax)。采用Kaplan-Meier法进行生存分析。建立了逻辑回归模型来确定独立的危险因素,并建立了结合早期死亡率和发病率的复合严重不良结局的列线图。
    VISmax与广泛的早期结局显着相关,例如早期死亡,肾损伤,心脏再手术和机械循环支持以等级依赖的方式,并预测90天和1年生存率(p<0.05)。制定了基于VIS的严重不良结果列线图,其中包括VISmax,术前晚期心力衰竭治疗,血红蛋白和血清肌酐。列线图经过很好的校准(Hosmer-Lemeshowp=0.424),具有中等到强的区分(C指数=0.745)和良好的临床实用性。
    VISmax是心脏移植中一个有价值的预后指标。在移植后的早期阶段,这个基于VIS的列线图可以很容易地帮助重症监护医师推断受者状态和指导术后管理.
    UNASSIGNED: In the early postoperative stage after heart transplantation, there is a lack of predictive tools to guide postoperative management. Whether the vasoactive-inotropic score (VIS) can aid this prediction is not well illustrated.
    UNASSIGNED: In total, 325 adult patients who underwent heart transplantation at our center between January 2015 and December 2018 were included. The maximum VIS (VISmax) within 24 h postoperatively was calculated. The Kaplan-Meier method was used for survival analysis. A logistic regression model was established to determine independent risk factors and to develop a nomogram for a composite severe adverse outcome combining early mortality and morbidity.
    UNASSIGNED: VISmax was significantly associated with extensive early outcomes such as early death, renal injury, cardiac reoperation and mechanical circulatory support in a grade-dependent manner, and also predicted 90-day and 1-year survival (p < 0.05). A VIS-based nomogram for the severe adverse outcome was developed that included VISmax, preoperative advanced heart failure treatment, hemoglobin and serum creatinine. The nomogram was well calibrated (Hosmer-Lemeshow p = 0.424) with moderate to strong discrimination (C-index = 0.745) and good clinical utility.
    UNASSIGNED: VISmax is a valuable prognostic index in heart transplantation. In the early post-transplant stage, this VIS-based nomogram can easily aid intensive care clinicians in inferring recipient status and guiding postoperative management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:本研究旨在探讨不同时间点血管活性-肌力评分(VIS)对成人先天性心脏病手术联合冠状动脉旁路移植术患者术后长时间机械通气(PMV)的预测价值。
    方法:患者被分为两组是否发生PMV。采用倾向评分匹配法降低两组间混杂因素的影响。不同时间点的VIS(手术结束时的VIS,VIS6h,VIS12h,和VIS12hmax)在手术后进行记录和计算。通过受试者工作特征(ROC)曲线分析VIS对PMV的预测价值,采用多因素logistic回归分析独立危险因素。
    结果:在250名患者中,PMV组52人,非PMV组198例。PMV率为20.8%。在倾向得分匹配后,94例患者配对。在每个时间点,通过VIS预测的PMV的ROC曲线下面积>0.500,其中手术结束时的VIS最大(0.805).VIS的最佳截止点6.5可以预测PMV,灵敏度为78.7%,特异性为72.3%。手术结束时VIS是PMV的独立危险因素(比值比=1.301,95%置信区间1.091~1.551,P<0.01)。
    结论:手术结束时的VIS是成人先天性心脏病手术合并冠状动脉旁路移植术患者PMV的独立预测因子。
    BACKGROUND: This study aimed to investigate the predictive value of the vasoactive-inotropic score (VIS) at different time points for postoperative prolonged mechanical ventilation (PMV) in adult congenital heart disease patients undergoing surgical treatment combined with coronary artery bypass grafting.
    METHODS: Patients were divided into two groups that developed PMV or not. The propensity score matching method was applied to reduce the effects of confounding factors between the two groups. VIS at different time points (VIS at the end of surgery, VIS6h, VIS12h, and VIS12h max) after surgery were recorded and calculated. The value of VIS in predicting PMV was analyzed by the receiver operating characteristic (ROC) curve, and multivariate logistic regression was used to analyze independent risk factors.
    RESULTS: Among 250 patients, 52 were in the PMV group, and 198 were in the non-PMV group. PMV rate was 20.8%. After propensity score matching, 94 patients were matched in pairs. At each time point, the area under the ROC curve predicted by VIS for PMV was > 0.500, among which VIS at the end of surgery was the largest (0.805). The optimal cutoff point for VIS of 6.5 could predict PMV with 78.7% sensitivity and 72.3% specificity. VIS at the end of surgery was an independent risk factor for PMV (odds ratio=1.301, 95% confidence interval 1.091~1.551, P<0.01).
    CONCLUSIONS: VIS at the end of surgery is an independent predictor for PMV in patients with adult congenital heart disease surgical treatment combined with coronary artery bypass grafting.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项研究评估了血管活性通气肾(VVR)评分在确定心脏手术后撤机失败风险方面的预测价值,并开发了列线图模型以帮助医生提高撤机成功率接受心脏手术后的成年患者的机械通气。
    回顾性收集了2022年8月至2023年4月在南京医科大学第一附属医院接受体外循环心脏手术的成年患者的临床数据,这些患者随后被转移到重症监护病房(ICU)并接受血管活性药物治疗。根据首次尝试断奶成功将患者分为成功和不成功断奶组。使用单变量逻辑回归和最小绝对收缩和选择算子(LASSO)正则化对变量选择进行正则化。进行多变量逻辑回归以确定预测因子,并创建列线图以预测断奶失败的风险。
    总共519名患者被纳入研究。选择多个逐步变量后,断奶前的VVR分数,断奶日改良序贯器官衰竭评估(mSOFA)评分,和撤机前机械通气持续时间被确定为心脏手术后成年患者撤机失败的预测指标。这些指标的最佳临界值为18.46分,4.33分,和20.50小时,分别。使用这三个因素构建的预测模型表现出良好的预测性能。
    断奶前的VVR评分可以准确预测心脏手术后成年患者断奶失败的概率。断奶风险预测列线图模型,基于VVR评分建立,mSOFA分数,和断奶前机械通气持续时间,表现出强大的预测能力。
    UNASSIGNED: This study evaluated the predictive value of the vasoactive-ventilation-renal (VVR) score in identifying the risk of weaning failure after cardiac surgery and developing a nomogram model to help physicians improve the success rate of weaning from mechanical ventilation in adult patients undergoing postoperative cardiac surgery.
    UNASSIGNED: Clinical data were retrospectively collected from adult patients who underwent extracorporeal circulation cardiac surgery at the First Affiliated Hospital of Nanjing Medical University between August 2022 and April 2023 and who were subsequently transferred to the Intensive Care Unit (ICU) and treated with vasoactive drugs. Patients were divided into successful and unsuccessful weaning groups based on first-attempt weaning success. Variable selection was regularized using univariate logistic regression and Least absolute shrinkage and selection operator (LASSO) regularization. Multivariate logistic regression was performed to identify predictors and a nomogram was created to predict the risk of weaning failure.
    UNASSIGNED: A total of 519 patients were included in the study. After selecting multiple stepwise variables, the VVR score before weaning, the modified Sequential Organ Failure Assessment (mSOFA) score on weaning day, and mechanical ventilation duration before weaning were determined as predictive indicators of weaning failure in adult patients after cardiac surgery. The optimal cut-off values for these indicators were 18.46 points, 4.33 points, and 20.50 h, respectively. The predictive model constructed using these three factors demonstrated good predictive performance.
    UNASSIGNED: The VVR score before weaning accurately predicts the probability of weaning failure in adult patients after cardiac surgery. The weaning risk-predictive nomogram model, established based on the VVR score, mSOFA score, and mechanical ventilation duration before weaning, demonstrated robust predictive ability.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:早期拔管(EEx)定义为术后8小时内拔除气管导管。本研究涉及确定血管活性肌力评分(VIS)的可用性和阈值,以预测选择性风湿性心脏瓣膜手术后成人的EEx。
    方法:本研究设计为一项单中心回顾性队列研究,对接受CPB选择性风湿性心脏瓣膜手术的成年人进行。本研究使用术后即刻最高的VIS。主要结果,使用ROC曲线分析确定用于EEx预测的VIS的可用性和最佳阈值。通过设置假阴性或假阳性率R=0.05进行VIS的灰色地带分析,并通过多因素logistic分析确定围手术期EEx延长的危险因素。比较不同VIS组术后并发症及预后。
    结果:在最初筛查的409名患者中,最终将379名患者纳入研究。EEx的发生率确定为112/379(29.6%)。VIS对EEx具有良好的预测价值(AUC=0.864,95%CI:[0.828,0.900],P<0.001)。EEx预测的最佳VIS阈值为16.5,敏感性为71.54%(65.85-76.61%),特异性为88.39%(81.15-93.09%)。确定VIS的灰色区域的上限和下限为(12,17.2)。多变量逻辑分析确定的年龄(OR,1.060;95%CI:1.017-1.106;P=0.006),EF%(OR,0.798;95%CI:0.742-0.859;P<0.001),GFR(或,0.933;95%CI:0.906-0.961;P<0.001),多瓣膜手术(或,4.587;95%CI:1.398-15.056;P=0.012),和VIS>16.5(或,12.331;95%CI:5.015-30.318;P<0.001)为EEx延长的独立危险因素。VIS≤16.5组的EEx成功率更高,更短的有创通气支持持续时间,且并发症发生率低于VIS>16.5组,而两组再插管的发生率相似。
    结论:在成年人中,在选择性风湿性心脏瓣膜手术后,术后即刻最高的VIS是EEx的良好预测价值,门槛为16.5。
    BACKGROUND: Early extubation (EEx) is defined as the removal of the endotracheal tube within 8 h postoperatively. The present study involved determining the availability and threshold of the vasoactive-inotropic score (VIS) for predicting EEx in adults after elective rheumatic heart valve surgery.
    METHODS: The present study was designed as a single-center retrospective cohort study which was conducted with adults who underwent elective rheumatic heart valve surgery with CPB. The highest VIS in the immediate postoperative period was used in the present study. The primary outcome, the availability of VIS for EEx prediction and the optimal threshold value were determined using ROC curve analysis. The gray zone analysis of the VIS was performed by setting the false negative or positive rate R = 0.05, and the perioperative risk factors for prolonged EEx were identified by multivariate logistic analysis. The postoperative complications and outcomes were compared between different VIS groups.
    RESULTS: Among the 409 patients initially screened, 379 patients were ultimately included in the study. The incidence of EEx was determined to be 112/379 (29.6%). The VIS had a good predictive value for EEx (AUC = 0.864, 95% CI: [0.828, 0.900], P < 0.001). The optimal VIS threshold for EEx prediction was 16.5, with a sensitivity of 71.54% (65.85-76.61%) and a specificity of 88.39% (81.15-93.09%). The upper and lower limits of the gray zone for the VIS were determined as (12, 17.2). The multivariate logistic analysis identified age (OR, 1.060; 95% CI: 1.017-1.106; P = 0.006), EF% (OR, 0.798; 95% CI: 0.742-0.859; P < 0.001), GFR (OR, 0.933; 95% CI: 0.906-0.961; P < 0.001), multiple valves surgery (OR, 4.587; 95% CI: 1.398-15.056; P = 0.012), and VIS > 16.5 (OR, 12.331; 95% CI: 5.015-30.318; P < 0.001) as the independent risk factors for the prolongation of EEx. The VIS ≤ 16.5 group presented a greater success rate for EEx, a shorter invasive ventilation support duration, and a lower incidence of complications than did the VIS > 16.5 group, while the incidence of reintubation was similar between the two groups.
    CONCLUSIONS: In adults, after elective rheumatic heart valve surgery, the highest VIS in the immediate postoperative period was a good predictive value for EEx, with a threshold of 16.5.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Meta-Analysis
    背景:本研究的目的是进行系统评价和荟萃分析,以检查血管活性-肌力评分(VIS)与手术患者预后之间的关系。
    方法:两名独立的审阅者搜索了PubMed,WebofScience,EMBASE,Scopus,科克伦图书馆,谷歌学者,和CNKI数据库从2010年11月开始,当VIS首次发布时,到2022年12月。通过手动搜索纳入研究的参考列表确定了其他研究。合格的研究是那些以英文发表的评估VIS与儿童和成人手术患者的短期或长期患者预后之间的关联的研究。使用RevManManager5.3版进行荟萃分析,质量评估遵循JoannaBriggs研究所(JBI)关键评估清单。
    结果:共有58项研究包括29,920名患者,其中34人符合荟萃分析的条件。发现术后早期VIS与长时间机械通气相关(OR5.20,95%CI3.78-7.16),死亡率(OR1.08,95%CI1.05-1.12),急性肾损伤(AKI)(OR1.26,95%CI1.13-1.41),不良结果(OR1.02,95%CI1.01-1.04),和ICU住院时间(LOS)(OR3.50,95%CI2.25-5.44)。VIS作为结果预测因子的最佳临界值在研究之间有所不同,范围从10到30。
    结论:术后早期VIS升高与各种不良结局相关,包括急性肾损伤(AKI),机械通气持续时间,死亡率,糟糕的结果,和ICU住院时间(LOS)。在返回重症监护病房(ICU)时监测VIS可以帮助医疗团队进行风险分层。有针对性的干预措施,和家长咨询。
    背景:PROSPEROCRD42022359100.
    The objective of this study is to conduct a systematic review and meta-analysis examining the relationship between the vasoactive-inotropic score (VIS) and patient outcomes in surgical settings.
    Two independent reviewers searched PubMed, Web of Science, EMBASE, Scopus, Cochrane Library, Google Scholar, and CNKI databases from November 2010, when the VIS was first published, to December 2022. Additional studies were identified through hand-searching the reference lists of included studies. Eligible studies were those published in English that evaluated the association between the VIS and short- or long-term patient outcomes in both pediatric and adult surgical patients. Meta-analysis was performed using RevMan Manager version 5.3, and quality assessment followed the Joanna Briggs Institute (JBI) Critical Appraisal Checklists.
    A total of 58 studies comprising 29,920 patients were included in the systematic review, 34 of which were eligible for meta-analysis. Early postoperative VIS was found to be associated with prolonged mechanical ventilation (OR 5.20, 95% CI 3.78-7.16), mortality (OR 1.08, 95% CI 1.05-1.12), acute kidney injury (AKI) (OR 1.26, 95% CI 1.13-1.41), poor outcomes (OR 1.02, 95% CI 1.01-1.04), and length of stay (LOS) in the ICU (OR 3.50, 95% CI 2.25-5.44). The optimal cutoff value for the VIS as an outcome predictor varied between studies, ranging from 10 to 30.
    Elevated early postoperative VIS is associated with various adverse outcomes, including acute kidney injury (AKI), mechanical ventilation duration, mortality, poor outcomes, and length of stay (LOS) in the ICU. Monitoring the VIS upon return to the Intensive Care Unit (ICU) could assist medical teams in risk stratification, targeted interventions, and parent counseling.
    PROSPERO CRD42022359100.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    如何引用这篇文章:在PICU中基于MagoonR.SOFA的预测:心血管批评!印度JCritCareMed2023;27(11):861-862。
    How to cite this article: Magoon R. SOFA-based Prognostication in PICU: A Cardiovascular Critique! Indian J Crit Care Med 2023;27(11):861-862.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号